- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 907209, 6 pages
Wound-Healing Potential of Cultured Epidermal Sheets Is Unaltered after Lyophilization: A Preclinical Study in Comparison to Cryopreserved CES
1Cutigen Research Institute, Tego Science Inc., Daerung Technotown III, 448 Gasan-Dong, Gumcheon-Gu, Seoul 153-772, Republic of Korea
2Department of Biosystems & Biomaterials Science and Engineering, Seoul National University, Seoul 151-921, Republic of Korea
Received 6 September 2013; Accepted 18 November 2013
Academic Editor: Paul Higgins
Copyright © 2013 H. Jang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Lyophilized Cultured Epidermal Sheets (L-CES) have been reported to be as effective as the cryopreserved CES (F-CES) in treating skin ulcers. However, unlike F-CES, no preclinical study assessing wound-healing effects has been conducted for L-CES. The present study was set out to investigate the microstructure, cytokine profile, and wound-healing effects of L-CES in comparison to those of F-CES. Keratinocytes were cultured to prepare CES, followed by cryopreservation at −70°C and lyophilization. Under microscopic observation, intact cells with apparent intracellular junctions were observed in L-CES. The L-CES, like fresh CES, consisted of three to four well-maintained epidermal layers, as shown by the expression of keratins, involucrin, and p63. There were no differences in the epidermal layer or protein expression between L-CES and F-CES, and both CES were comparable to fresh CES. TGF-, EGF, VEGF, IL-1, and MMPs were detected in L-CES at levels similar to those in F-CES. In a mouse study, wounds treated with L-CES or F-CES completely healed at least 4 days faster than untreated wounds. CES-treated wounds completely healed by day 10, while the untreated wounds did not heal by day 14. Masson’s trichrome staining showed that collagen deposition in the CES-treated wounds was highly increased in the dermis of the wound center compared to that in the control wounds. Thus, this study demonstrates that L-CES is as clinically effective as F-CES for wound treatment.
It was shown in the late 1980s that CES of allogeneic keratinocytes, unlike their autologous counterpart, are not permanent, instead serving as a temporary biological dressing that releases proteins involved in the proliferation and migration of keratinocytes and fibroblasts. Proteins that act in concert to promote wound healing include growth factors such as bFGF, TGF-α, TGF-β, EGF, VEGF, and PDGF, cytokines such as IL-1α, IL-6, and IL-8, and extracellular matrix proteins such as collagen, laminin, tenascin, and fibronectin [4–6].
Allogeneic CES, prepared from a cell bank established from an infant skin biopsy, have advantages over autologous CES in that the time taken to obtain CES from primary culture is much shorter compared to autologous CES. In order for the allogeneic CES to be readily available, however, it is necessary to store them for some period of time without compromising their biological nature.
Studies have demonstrated that the F-CES are as effective as freshly prepared CES in treating partial-thickness wounds [7, 8]. Furthermore, L-CES were also shown to successfully treat chronic leg ulcers [9, 10]. Because lyophilization seems to provide a convenient and cost-effective way to prepare ready-made CES on a large scale, we were curious to know whether the wound-healing effects of L-CES are comparable to F-CES.
2. Materials and Methods
2.1. Preparation of F-CES and L-CES
Human keratinocytes were cultured as described in Barrandon and Green to form a sheet  that was detached from the culture flask using dispase . For cryopreservation, the resulting CES were treated with a cryoprotectant containing human serum albumin in DMEM and then frozen at −70°C. Before lyophilization, CES were treated with a lyoprotectant of 5% polyethylene glycol (PEG), 1% trehalose, and cryoprotectant and then frozen at −40°C. More than 12 hours later, lyophilization was performed through a gradual increase in temperature at the rate of 1°C per minute from −40°C to 25°C under vacuum pressure of less than 10 mTorr in a lyophilizer (Ilshin Biobase, Seoul, South Korea).
2.2. Microstructural Observation of CES
The sheet surface of CES was observed using a field-emission scanning electron microscope (FE-SEM) (SUPRA 55VP, Carl Zeiss, Oberkochen, Germany). The cross sections of CES were examined for cell-cell junctions with a transmission electron microscope (TEM) (JEM1010, JEOL, Akishima, Tokyo, Japan).
2.3. Immunofluorescence Staining (IF)
Monoclonal antibodies raised against K1 (Abcam, Cambridge, MA, USA), K14 (AbD Serotec, Raleigh, NC, USA), involucrin (Sigma-Aldrich, St. Louis, MO, USA), and p63 (BD Pharmingen, San Jose, CA, USA) were used with secondary antibodies including anti-mouse IgG conjugated with either FITC (Jackson Immuno Research Laboratories Inc., West Grove, PA, USA) or rhodamine (Invitrogen, Grand Island, NY, USA). A mounting medium containing DAPI (Vector, Burlingame, CA, USA) was used for nuclear staining. IF images were observed with an Anaxioskop 40 FL Microscope (Carl Zeiss).
2.4. ELISA Assay
Protein extracts from CES were prepared by repeated freezing and thawing followed by homogenization. Commercially available ELISA kits were used according to the manufacturer’s instructions (R&D Systems, Minneapolis, MN, USA) to measure the levels of proteins involved in wound healing.
2.5. In Vivo Wound-Healing Assay
All animal experiments were approved by the Seoul National University Institutional Care and Use Committee (approval number: SNU-120116-4). The wound-healing assay was performed using 8~12-week-old ICR mice . Specifically, two full-thickness wounds 1.2 cm in diameter were made on the back of each mouse by excising the skin and were covered with either F-CES or L-CES. Vaseline gauze was applied in all groups, and the control wound was covered with Vaseline gauze only. The wound was treated with each graft once for 14 days without graft changes or additional treatment. The animals were sacrificed at days 4, 7, 10, and 14 after injury for histological analysis. Complete wounds were isolated, fixed overnight in 10% formalin, and embedded in paraffin. To compare collagen deposition, Masson’s trichrome staining was performed on the paraffin sections.
2.6. Statistical Analysis
Student’s t-test was used to compare the differences in protein levels between F-CES and L-CES and in wound-healing assay between F-CES or L-CES and control. values <0.05 were considered significant.
3.1. Epidermal Structure of L-CES
To prepare CES that are suitable for long-term storage and convenient handling, attempts to lyophilize CES were undertaken under the conditions described in Section 2. CES have been shown to be mainly composed of basal and spinous keratinocytes adhered via desmosomes and other adhesion proteins such as E-cadherin and β-catenin . The microstructure of L-CES, as determined by scanning electron microscopy (SEM), appeared to be intact with apparent cell-cell junctions observed by TEM (Figure 1). The hematoxylin and eosin (H&E)-stained cross sections of L-CES revealed epidermal characteristics similar to both fresh CES and F-CES (Figure 2). In the epidermis, three to four cell layers were observed. The basal layers were positive for K14 and p63, and suprabasal layers were positive for K1 and involucrin by immunofluorescence staining. These data indicate that the lyophilization process did not harm the CES at least from a morphological point of view.
3.2. Growth Factors, Cytokines, and MMPs in L-CES
Allogeneic CES have paracrine effects on wounds that are mediated by the release of proteins. The presence of the paracrine factors TGF-α, bFGF, EGF, VEGF, and IL-1α in L-CES was investigated. ELISA data showed that VEGF and IL-1α were detected at high levels in L-CES that were comparable to those in F-CES. TGF-α, EGF, and bFGF were also detected in both F-CES and L-CES (Figure 3). Therefore, CES, regardless of their physical states (frozen or lyophilized), are expected to exert similar paracrine effects on wound healing. In addition, matrix metalloproteases (MMPs) such as MMP-2 and MMP-9 were found in L-CES at similar or higher levels than in F-CES, although the difference was not statistically significant (Figure 3). These enzymes are known to play an important role in controlling the overproduction of collagen and thus in reducing hypertrophic scars in vivo . These results lead us to believe that lyophilization does not compromise the protein levels of CES involved in wound healing and scar formation.
3.3. In Vivo Wound Healing in Mice
To compare the wound-healing effect of L-CES and F-CES, two full-thickness wounds were created on the back of ICR mice and were either treated with F-CES or L-CES or were left untreated (Figure 4). We measured nonreepithelialized area, and the size of the unhealed fraction of the wound was measured at 4, 7, 10, and 14 days after wounding. The percentage of unhealed area over the initial wound size was calculated to evaluate the healing effect. Wound size was effectively decreased in wounds treated with either F-CES or L-CES, to 20.8% and 26.4%, respectively, whereas it was 55.9% in untreated controls on day 4 (Figures 4(a) and 4(b)).
By day 7, the wounds treated with either form of CES were reduced to less than 10% and were half the size of the control wounds. Even on the 10th day, unhealed area for wounds treated with either CES was 1.4%, which can be regarded as complete closure (<2.0%) in our experimental setting. A continued decrease in size to complete closure was observed by day 14 (0.1%). In contrast, the control wounds were not fully closed, with a 12.1% unhealed fraction on day 14. Therefore, healing capacity of F-CES () and L-CES () was significant compared to that of untreated control on day 14. Reepithelialization was shown in the wound center in both F-CES- and L-CES-treated wounds at day 14, whereas it was not observed in the wound center in untreated controls (Figure 4(c)). Finally, CES-treated wounds completely healed by day 10, while the untreated wounds had only partially healed by day 14.
Collagen deposition was detected at high levels in both F-CES- and L-CES-treated wounds. Collagen deposition in the wound center was significantly increased in both F-CES- and L-CES- treated wounds compared to untreated controls. It should be emphasized that we did not notice any difference between L-CES and F-CES in their ability to promote wound healing in mice.
Since the technologies to culture keratinocytes in vitro to form a sheet and to detach it from culture flasks were established in late 1970s, CES have been used to treat severely burned patients by providing keratinocyte stem cells for reepithelialization of the wounded areas [3, 15]. CES composed of allogeneic keratinocytes, in particular, could be defined as a biological dressing that exerts its wound-healing effects by releasing multiple proteins including growth factors, cytokines, and extracellular matrix proteins. When epidermal and/or follicular stem cells remain in or around a wound, CES have been reported to stimulate these stem cells to proliferate, migrate, and eventually cover the entire wound [4–6]. It was evident that the regenerated epithelium consisted of the patient’s own keratinocytes instead of those provided by the CES [16, 17].
In order for CES to be readily available, different methods of cryopreserving them for a substantial period of time without compromising their biological activities have been developed. The resulting cryopreserved CES have been clinically shown to have healing effects similar to freshly prepared CES  and have been successfully commercialized (Kaloderm, Tego Science Inc., Seoul, South Korea). Although cryopreservation can make it possible to culture CES in quantity and to apply them immediately to the wounds whenever needed, it is cumbersome to maintain deep freezers equipped with electrical generator systems in case of power failure and to deliver F-CES over distances using dry ice. Once these disadvantages are overcome, the market potential of CES is expected to rise tremendously due to their outstanding efficacy. A few studies have described the clinical application of L-CES to skin ulcers as an alternative to F-CES [9, 10]. However, those studies are limited in that L-CES have never been characterized in vitro in terms of their structural integrity or biological characteristics. In our study, the structural and morphological integrity of L-CES were examined. The cross sections of L-CES were comparable to those of both fresh CES and F-CES in terms of their expression of epidermal marker proteins such as K14, K1, and involucrin. In addition, the levels of proteins, including growth factors and matrix metalloproteases, known to be involved in wound healing were similar in L-CES and F-CES. These results indicate that the lyophilization process did not compromise the biological activity of the CES. These in vitro results were further confirmed by an in vivo wound-healing study. In mice, both F-CES and L-CES demonstrated similar healing effects on full-thickness wounds. Wound-healing process involves reepithelialization, contraction, and connective tissue deposition, and these steps of wound healing act concurrently. We demonstrated that reepithelialization in histological analysis was completed in wounds treated with L-CES or F-CES while it was not completed in untreated wound at day 14. Wounds treated with L-CES or F-CES revealed that the collagen deposition was abundant in Masson’s trichrome staining. Therefore, both in vitro and in vivo data suggest that lyophilization, similar to cryopreservation, is a useful option to preserve the wound-healing proteins and, therefore, the healing effect of CES. In addition, L-CES are comparable to lyophilized keratinocyte lysates in that the same set of proteins is implicated and clinically active in wound healing [19, 20]. However, L-CES are presumed to be more stable because the integrity of cells is maintained after lyophilization, although cells could be partially lysed.
Lyophilization is one of the most practical methods of long-term preservation at room temperature in a variety of industries including food, agriculture, cosmetics, and medicine. However, the lyophilization of biological products has been confined to purified materials, such as growth factors and hormones, the microorganisms used for forage and vaccines, because they are likely to be functionally unaffected by the process in comparison to mammalian cells . Trial and error was used to establish optimal conditions under which CES without changing their biological activities in this study were lyophilized (publication in preparation). In brief, we treated CES with an undisclosed combination of polyethylene glycol (PEG), proteins, and sugars and lyophilized them under the conditions described in Section 2. These lyophilization conditions allowed CES to be biologically stable over a period of months at room temperature. Further studies remain to be conducted to fine-tune the lyophilization conditions and prolong the allowable storage of L-CES at room temperature.
L-CES have been reported to be as clinically effective as F-CES in wound healing. In the present study, L-CES were analyzed to show that their structural integrity, epidermal structure, cytokine contents, and wound-healing capacity are unchanged by the lyophilization process. Therefore, we conclude that lyophilization may be a means to have CES readily available at room temperature without affecting their biological activities in wound healing.
Conflict of Interests
The authors, S. Jeon, H. Jang, and Y. H. Kim, who are members of Tego Science Inc., declare that they have no conflict of interests.
This research was supported by the RNBD program of the City of Seoul (JP100079).
- J. G. Rheinwald and H. Green, “Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells,” Cell, vol. 6, no. 3, pp. 331–334, 1975.
- H. Green, O. Kehinde, and J. Thomas, “Growth of cultured human epidermal cells into multiple epithelia suitable for grafting,” Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 11, pp. 5665–5668, 1979.
- H. Green, “The birth of therapy with cultured cells,” BioEssays, vol. 30, no. 9, pp. 897–903, 2008.
- G. C. Gurtner, S. Werner, Y. Barrandon, and M. T. Longaker, “Wound repair and regeneration,” Nature, vol. 453, no. 7193, pp. 314–321, 2008.
- E. Tamariz-Domínguez, F. Castro-Muñozledo, and W. Kuri-Harcuch, “Growth factors and extracellular matrix proteins during wound healing promoted with frozen cultured sheets of human epidermal keratinocytes,” Cell and Tissue Research, vol. 307, no. 1, pp. 79–89, 2002.
- M. M. Santoro and G. Gaudino, “Cellular and molecular facets of keratinocyte reepithelization during wound healing,” Experimental Cell Research, vol. 304, no. 1, pp. 274–286, 2005.
- H. Yanaga, Y. Udoh, T. Yamauchi et al., “Cryopreserved cultured epidermal allografts achieved early closure of wounds and reduced scar formation in deep partial-thickness burn wounds (DDB) and split-thickness skin donor sites of pediatric patients,” Burns, vol. 27, no. 7, pp. 689–698, 2001.
- C. Alvarez-Diaz, J. Cuenca-Pardo, A. Sosa-Serrano, E. Juarez-Aguilar, M. Marsch-Moreno, and W. Kuri-Harcuch, “Controlled clinical study of deep partial-thickness burns treated with frozen cultured human allogeneic epidermal sheets,” Journal of Burn Care and Rehabilitation, vol. 21, no. 4, pp. 291–299, 2000.
- Z. Navrátilová, V. Slonková, V. Semrádová, and J. Adler, “Cryopreserved and lyophilized cultured epidermal allografts in the treatment of leg ulcers: a pilot study,” Journal of the European Academy of Dermatology and Venereology, vol. 18, no. 2, pp. 173–179, 2004.
- V. Slonkova, Z. Navratilova, V. Semradova, and J. Adler, “Successful treatment of chronic venous leg ulcers with lyophilized cultured epidermal allografts,” Acta Dermatovenerologica Alpina, Panonica, Et Adriatica, vol. 13, no. 4, pp. 119–123, 2004.
- Y. Barrandon and H. Green, “Three clonal types of keratinocyte with different capacities for multiplication,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 8, pp. 2302–2306, 1987.
- E. Tamariz, M. Marsch-Moreno, F. Castro-Muñozledo, V. Tsutsumi, and W. Kuri-Harcuch, “Frozen cultured sheets of human epidermal keratinocytes enhance healing of full-thickness wounds in mice,” Cell and Tissue Research, vol. 296, no. 3, pp. 575–585, 1999.
- F. M. Watt, “Epidermal stem cells: markers, patterning and the control of stem cell fate,” Philosophical Transactions of the Royal Society B, vol. 353, no. 1370, pp. 831–837, 1998.
- S. E. Gill and W. C. Parks, “Metalloproteinases and their inhibitors: regulators of wound healing,” International Journal of Biochemistry and Cell Biology, vol. 40, no. 6-7, pp. 1334–1347, 2008.
- G. Pellegrini, R. Ranno, G. Stracuzzi et al., “The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin,” Transplantation, vol. 68, no. 6, pp. 868–879, 1999.
- A. Brain, P. Purkis, P. Coates, M. Hackett, H. Navsaria, and I. Leigh, “Survival of cultured allogenic keratinocytes transplanted to deep dermal bed assessed with probe specific for Y chromosome,” British Medical Journal, vol. 298, no. 6678, pp. 917–919, 1989.
- V. B. Morhenn, C. J. Benike, and A. J. Cox, “Cultured human epidermal cells do not synthesize HLA-DR,” Journal of Investigative Dermatology, vol. 78, no. 1, pp. 32–37, 1982.
- R. G. C. Teepe, E. J. Koebrugge, M. Ponec, and B. J. Vermeer, “Fresh versus cryopreserved cultured allografts for the treatment of chronic skin ulcers,” British Journal of Dermatology, vol. 122, no. 1, pp. 81–89, 1990.
- L. Duinslaeger, G. Verbeken, P. Reper, B. Delaey, S. Vanhalle, and A. Vanderkelen, “Lyophilized keratinocyte cell lysates contain multiple mitogenic activities and stimulate closure of meshed skin autograft-covered burn wounds with efficiency similar to that of fresh allogeneic keratinocyte cultures,” Plastic and Reconstructive Surgery, vol. 98, no. 1, pp. 110–117, 1996.
- T. Somers, L. Duinslaeger, B. Delaey et al., “Stimulation of epithelial healing in chronic postoperative otorrhea using lyophilized cultured keratinocyte lysates,” The American Journal of Otology, vol. 18, no. 6, pp. 702–706, 1997.
- T. Kanias and J. P. Acker, “Mechanism of hemoglobin-induced cellular injury in desiccated red blood cells,” Free Radical Biology and Medicine, vol. 49, no. 4, pp. 539–547, 2010.